KMT2A/C mutations function as a potential predictive biomarker for immunotherapy in solid tumors

por Zhang, Rui, Wu, Hao-Xiang, Xu, Ming, Xie, Xiaoyan
Publicado 2020

Advancing to the era of cancer immunotherapy

por Wang, Yun, Wang, Min, Wu, Hao‐Xiang, Xu, Rui‐Hua
Publicado 2021

Designing gene panels for tumor mutational burden estimation: the need to shift from ‘correlation’ to ‘accuracy’

por Wu, Hao-Xiang, Wang, Zi-Xian, Zhao, Qi, Wang, Feng, Xu, Rui-Hua
Publicado 2019

EPHA7 mutation as a predictive biomarker for immune checkpoint inhibitors in multiple cancers

por Zhang, Zhen, Wu, Hao-Xiang, Lin, Wu-Hao, Wang, Zi-Xian, Yang, Lu-Ping, Zeng, Zhao-Lei, Luo, Hui-Yan
Publicado 2021

Exploration of modified progression-free survival as a novel surrogate endpoint for overall survival in immuno-oncology trials

por Wang, Zi-Xian, Wu, Hao-Xiang, Xie, Li, Lin, Wu-Hao, Liang, Fei, Li, Jin, Yang, Zhi-Min, Xu, Rui-Hua
Publicado 2021

Alteration in TET1 as potential biomarker for immune checkpoint blockade in multiple cancers

por Wu, Hao-Xiang, Chen, Yan-Xing, Wang, Zi-Xian, Zhao, Qi, He, Ming-Ming, Wang, Ying-Nan, Wang, Feng, Xu, Rui-Hua
Publicado 2019

Appraisal of Prognostic Interaction between Sidedness and Mucinous Histology in Colon Cancer: A Population-Based Study Using Inverse Probability Propensity Score Weighting

por Wang, Zi-Xian, Yang, Lu-Ping, Wu, Hao-Xiang, Yang, Dong-Dong, Ding, Pei-Rong, Xie, Dan, Chen, Gong, Li, Yu-Hong, Wang, Feng, Xu, Rui-Hua
Publicado 2019

Elevated peripheral blood neutrophil-to-lymphocyte ratio is associated with an immunosuppressive tumour microenvironment and decreased benefit of PD-1 antibody in advanced gastric...

por Ruan, Dan-Yun, Chen, Yan-Xing, Wei, Xiao-Li, Wang, Ying-Nan, Wang, Zi-Xian, Wu, Hao-Xiang, Xu, Rui-Hua, Yuan, Shu-Qiang, Wang, Feng-Hua
Publicado 2021

Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response

por Zhang, Zhen, Wang, Zi-Xian, Chen, Yan-Xing, Wu, Hao-Xiang, Yin, Ling, Zhao, Qi, Luo, Hui-Yan, Zeng, Zhao-Lei, Qiu, Miao-Zhen, Xu, Rui-Hua
Publicado 2022

Two-Dimensional Shear Wave Elastography Evaluation of Post-transplantation Complications in Pediatric Receipt: A Retrospective Cohort

por Gu, Li-hong, Lv, Zi-cheng, Wu, Hao-xiang, Hou, Yu-Chen, Gao, Run-lin, Xi, Zhi-feng, Fang, Hua, Feng, Hao, Jiang, Li-xin, Xia, Qiang
Publicado 2022

Clinical Benefit of First-Line Programmed Death-1 Antibody Plus Chemotherapy in Low Programmed Cell Death Ligand 1–Expressing Esophageal Squamous Cell Carcinoma: A Post Hoc Analysi...

por Wu, Hao-Xiang, Pan, Yi-Qian, He, Ye, Wang, Zi-Xian, Guan, Wen-Long, Chen, Yan-Xing, Yao, Yi-Chen, Shao, Ning-Yi, Xu, Rui-Hua, Wang, Feng
Publicado 2023

MFSD2A potentiates gastric cancer response to anti‐PD‐1 immunotherapy by reprogramming the tumor microenvironment to activate T cell response

por Zhang, Bin, Wang, Chun‐Mei, Wu, Hao‐Xiang, Wang, Feng, Chai, Yang‐Yang, Hu, Ye, Wang, Bing‐Jing, Yu, Zhou, Xia, Rong‐Hua, Xu, Rui‐Hua, Cao, Xue‐Tao
Publicado 2023

Neoadjuvant Programmed Cell Death 1 (PD-1) Inhibitor Treatment in Patients With Hepatocellular Carcinoma Before Liver Transplant: A Cohort Study and Literature Review

por Qiao, Zi-yun, Zhang, Zi-jie, Lv, Zi-cheng, Tong, Huan, Xi, Zhi-feng, Wu, Hao-xiang, Chen, Xiao-song, Xia, Lei, Feng, Hao, Zhang, Jian-jun, Xia, Qiang
Publicado 2021

Comprehensive genomic characterization of sporadic synchronous colorectal cancer: Implications for treatment optimization and clinical outcome

por Yang, Lu-Ping, Jiang, Teng-Jia, He, Ming-Ming, Ling, Yi-Hong, Wang, Zi-Xian, Wu, Hao-Xiang, Zhang, Zhen, Xu, Rui-Hua, Wang, Feng, Yuan, Shu-Qiang, Zhao, Qi
Publicado 2023

Transplantation for EASL-CLIF and APASL acute-on-chronic liver failure (ACLF) patients: The TEA cohort to evaluate long-term post-Transplant outcomes

por Xia, Lei, Qiao, Zi-yun, Zhang, Zi-jie, Lv, Zi-cheng, Tong, Huan, Tong, Ying, Wu, Hao-xiang, Chen, Xiao-song, Sun, Han-yong, Zhang, Jian-jun, Thasler, Wolfgang Ervin, Feng, Hao, Xia, Qiang
Publicado 2022

Correlation of Milestone Restricted Mean Survival Time Ratio With Overall Survival Hazard Ratio in Randomized Clinical Trials of Immune Checkpoint Inhibitors: A Systematic Review a...

por Wang, Zi-Xian, Wu, Hao-Xiang, Xie, Li, Wang, Ying-Nan, Yang, Lu-Ping, He, Ming-Ming, Luo, Hui-Yan, Ding, Pei-Rong, Xie, Dan, Chen, Gong, Li, Yu-Hong, Wang, Feng, Xu, Rui-Hua
Publicado 2019

A real-world evidence of efficacy of palliative gastrectomy plus chemotherapy in metastatic gastric cancer patients

por Yang, Lu-Ping, Wang, Zi-Xian, He, Ming-Ming, Wu, Hao-Xiang, Yuan, Shu-Qiang, Wang, Wei, Jin, Ying, Ren, Chao, Wang, Zhi-Qiang, Wang, Feng-Hua, Li, Yu-Hong, Wang, Feng, Xu, Rui-Hua
Publicado 2019

Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer

por Chen, Gong, Peng, Junjie, Xiao, Qian, Wu, Hao-Xiang, Wu, Xiaojun, Wang, Fulong, Li, Liren, Ding, Peirong, Zhao, Qi, Li, Yaqi, Wang, Da, Shao, Yang, Bao, Hua, Pan, Zhizhong, Ding, Ke-Feng, Cai, Sanjun, Wang, Feng, Xu, Rui-Hua
Publicado 2021

Genomic temporal heterogeneity of circulating tumour DNA in unresectable metastatic colorectal cancer under first-line treatment

por Wang, Feng, Huang, You-Sheng, Wu, Hao-Xiang, Wang, Zi-Xian, Jin, Ying, Yao, Yi-Chen, Chen, Yan-Xing, Zhao, Qi, Chen, Shifu, He, Ming-Ming, Luo, Hui-Yan, Qiu, Miao-Zhen, Wang, De-shen, Wang, Feng-Hua, Xu, Mingyan, Li, Yu-Hong, Xu, Rui-Hua
Publicado 2022